BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19962924)

  • 1. Mature IGF-II prevents the formation of "big" IGF-II/IGFBP-2 complex in the human circulation.
    Qiu Q; Yan X; Bell M; Di J; Tsang BK; Gruslin A
    Growth Horm IGF Res; 2010 Apr; 20(2):110-7. PubMed ID: 19962924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
    Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
    Zapf J; Futo E; Peter M; Froesch ER
    J Clin Invest; 1992 Dec; 90(6):2574-84. PubMed ID: 1281841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation.
    Holman SR; Baxter RC
    Growth Regul; 1996 Mar; 6(1):42-7. PubMed ID: 8717449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
    Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
    J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].
    Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U
    Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
    van Doorn J; van de Hoef W; Dullaart RP
    Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
    Daughaday WH; Trivedi B; Baxter RC
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
    van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
    Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.